Waltz Comments on CMS Blanket Waivers of Hospital Stay Requirements Amid COVID-19 Pandemic
23 March 2020
Report on Medicare Compliance
Partner Judith Waltz was quoted in the Report on Medicare Compliance article, “COVID-19 Waivers: Some SNFs Refuse Hospital Patients Anyway, MA Coverage is Better” about CMS’ blanket waiver of hospital stay requirements during the COVID-19 pandemic as a way to free up hospital beds.
The blanket waivers for excluded-part units are based on cost-report categories, Waltz said. “This gives hospitals flexibility to use the space without worrying about the cost-report implications.”
Waltz added that the waivers for skilled nursing facilities are heartfelt. “This is a recognition that the beneficiaries are suffering,” she said. Waltz said she understands, however, that given their vulnerability, skilled nursing facilities may hope patients complete three-day in hospital stays prior to be transferred to their facilities and are in better shape by the time they get there.
Waltz is the co-chair of Foley’s Health Care Industry Team.
(Subscription required)
People
Related News
06 September 2024
In the News
Old Employment Law Principles Can Answer New AI Concerns
The integration of artificial intelligence into the workplace has sparked a flurry of legal and regulatory discussions in recent months.
06 September 2024
In the News
Nathaniel Lacktman, Foley's 50-State Survey of Telehealth Insurance Laws Highlighted for Guidance on Legal Landscape
Foley & Lardner LLP partner Nathaniel Lacktman, chair of the firm’s national Telemedicine & Digital Health Industry Team and member of the American Telemedicine Association Board of Directors, discussed telehealth reimbursement parity, exclusivity contracts, and remote patient monitoring in the Managed Healthcare Executive article, “Telehealth is a Go, and States Are Having Their Say So.”
05 September 2024
In the News
Nathaniel Lacktman on Potential DEA Telemedicine Prescribing Crackdown – 'It's putting doctors in a really difficult situation'
Foley & Lardner LLP partner Nathaniel Lacktman, chair of firm’s national Telemedicine & Digital Health Industry Team and member of the American Telemedicine Association Board of Directors, discussed the potential consequences of the U.S. Drug Enforcement Agency enacting regressive regulations on telemedicine prescribing in Endpoints News, a Financial Times publication.